Presentations made painless

Company > Avid Bioservices Inc: Business Model, SWOT Analysis, and Competitors 2023

Avid Bioservices Inc: Business Model, SWOT Analysis, and Competitors 2023

Published: Apr 11, 2023

Inside This Article


    In this blog article, we will delve into a comprehensive analysis of Avid Bioservices Inc., focusing on its business model, SWOT analysis, and key competitors. Avid Bioservices is a renowned biotechnology company that specializes in providing contract development and manufacturing services to the biopharmaceutical industry. By examining its business model, we will gain insights into how the company operates and generates revenue. Additionally, a SWOT analysis will highlight the strengths, weaknesses, opportunities, and threats that Avid Bioservices faces in the market. Lastly, we will explore its key competitors to understand the competitive landscape of the industry in 2023.

    What You Will Learn:

    • Who owns Avid Bioservices Inc and the importance of understanding the ownership structure of a company.
    • The mission statement of Avid Bioservices Inc and how it guides the company's actions and goals.
    • How Avid Bioservices Inc makes money and the key revenue streams that contribute to its financial success.
    • The explanation of Avid Bioservices Inc's business model canvas and how it helps in understanding the various aspects of its operations.
    • The main competitors of Avid Bioservices Inc and the competitive landscape in which the company operates.
    • A SWOT analysis of Avid Bioservices Inc, analyzing its strengths, weaknesses, opportunities, and threats to provide a comprehensive understanding of the company's position in the market.

    Who owns Avid Bioservices Inc?

    Major Shareholders of Avid Bioservices Inc.

    When it comes to determining ownership in a company, one of the key factors to consider is the distribution of shares among the shareholders. Avid Bioservices Inc. is no exception, and its ownership structure reflects the level of investment and influence various entities have in the company.

    The largest shareholders of Avid Bioservices Inc. are institutional investors, including mutual funds and investment firms. These institutions hold significant stakes in the company and play a crucial role in shaping its direction and decision-making. Some of the major institutional shareholders of Avid Bioservices Inc. include Vanguard Group, BlackRock, and State Street Corporation.

    Apart from institutional investors, there are also individual shareholders who own shares in Avid Bioservices Inc. These individual investors can range from company executives and employees to retail investors who have purchased shares on the stock market. While their individual holdings may be smaller compared to institutional investors, the collective impact of their ownership should not be underestimated.

    Furthermore, it's important to note that there may be insiders who hold shares in Avid Bioservices Inc. These insiders can include members of the company's board of directors, executives, and other employees. Their ownership stakes not only demonstrate their confidence in the company but also align their interests with those of the shareholders.

    Overall, the ownership of Avid Bioservices Inc. is a combination of institutional investors, individual shareholders, and insiders. This diverse ownership structure ensures a balance of perspectives and interests, contributing to the company's overall stability and growth.

    What is the mission statement of Avid Bioservices Inc?

    The Mission Statement of Avid Bioservices Inc

    Avid Bioservices Inc is a contract development and manufacturing organization (CDMO) that provides comprehensive services to the biotechnology and pharmaceutical industries. With a focus on delivering high-quality development and manufacturing solutions, the company has a clear mission statement that guides its operations.

    The mission statement of Avid Bioservices Inc is to "partner with our clients to advance their innovative biologic products, utilizing our expertise in development, manufacturing, and regulatory compliance to deliver transformative solutions that improve patient outcomes."

    This mission statement highlights the core values and goals of Avid Bioservices Inc. The company aims to be a trusted partner for its clients, working collaboratively to support the development and manufacturing of their biologic products. Utilizing their extensive expertise in the field, Avid Bioservices Inc strives to provide transformative solutions that ultimately benefit patients and improve their overall outcomes.

    Avid Bioservices Inc recognizes the importance of quality and regulatory compliance in the biotechnology and pharmaceutical industries. Their mission statement emphasizes their commitment to delivering high-quality services that meet the stringent regulatory requirements. By adhering to these standards, Avid Bioservices Inc ensures the safety, efficacy, and reliability of the products they develop and manufacture.

    Moreover, this mission statement also highlights Avid Bioservices Inc's dedication to innovation. The company aims to advance the field of biotechnology by supporting the development of innovative biologic products. Through their expertise in development and manufacturing, Avid Bioservices Inc contributes to the progress and breakthroughs in the biotechnology and pharmaceutical industries.

    Overall, the mission statement of Avid Bioservices Inc reflects their commitment to partnership, quality, regulatory compliance, and innovation. By staying true to their mission, Avid Bioservices Inc continues to be a leading CDMO, supporting their clients in bringing novel biologic products to market while improving patient outcomes.

    How does Avid Bioservices Inc make money?

    Contract development and manufacturing organization (CDMO) services

    One of the primary ways that Avid Bioservices Inc generates revenue is through its contract development and manufacturing organization (CDMO) services. As a CDMO, Avid Bioservices offers a wide range of biopharmaceutical development and manufacturing services to its clients.

    Under this business model, Avid Bioservices collaborates with biotech and pharmaceutical companies to develop and manufacture their drug candidates. This includes providing services such as process development, analytical testing, formulation development, and manufacturing of clinical and commercial-stage biologics.

    By leveraging its expertise in bioprocessing and state-of-the-art manufacturing facilities, Avid Bioservices generates revenue by charging its clients for the services rendered. These services can be customized to meet the specific needs of each client, allowing Avid Bioservices to cater to a diverse range of projects.

    Long-term contracts and recurring revenue

    Avid Bioservices focuses on establishing long-term partnerships with its clients, which can span several years. These contracts often involve multi-year commitments for the development and manufacturing of a specific drug candidate or multiple products.

    This emphasis on long-term contracts provides Avid Bioservices with a steady stream of recurring revenue. It allows the company to plan its resources and capacity utilization more efficiently, reducing the risk of revenue fluctuations commonly associated with shorter-term contracts.

    Furthermore, these long-term partnerships often lead to additional opportunities for Avid Bioservices. As clients progress through different stages of drug development, they may require additional services or manufacturing capacity. Avid Bioservices can capitalize on these opportunities to generate additional revenue and strengthen its relationships with clients.

    Revenue from proprietary products

    In addition to its CDMO services, Avid Bioservices also earns revenue from its proprietary products. The company has developed its own portfolio of biologics, including antibodies and other therapeutic proteins.

    Avid Bioservices advances these proprietary products through different stages of development, from preclinical to clinical trials. As the products progress successfully, the company can generate revenue through licensing agreements or partnerships with pharmaceutical companies interested in commercializing these products.

    This diversification of revenue streams, combining CDMO services and proprietary products, helps Avid Bioservices mitigate risks and enhance its financial stability. It allows the company to leverage its expertise in biomanufacturing while simultaneously pursuing its own product pipeline.

    By diversifying its revenue sources and focusing on long-term partnerships, Avid Bioservices Inc has established a sustainable business model that enables it to generate consistent revenue and foster growth in the biopharmaceutical industry.

    Avid Bioservices Inc Business Model Canvas Explained

    Introduction to Avid Bioservices Inc

    Avid Bioservices Inc is a contract development and manufacturing organization (CDMO) that specializes in biopharmaceutical products. With over 25 years of experience in the industry, Avid Bioservices has established itself as a trusted partner for biotech and pharmaceutical companies seeking a reliable and efficient manufacturing solution.

    What is a Business Model Canvas?

    A business model canvas is a strategic management tool that provides a visual representation of a company's business model. It allows organizations to clearly define and analyze the key elements that drive their operations, revenue streams, and value proposition. The canvas consists of nine building blocks that cover various aspects of a business, including customer segments, key activities, resources, partnerships, and cost structure.

    Key Elements of Avid Bioservices Inc's Business Model Canvas

    1. Customer Segments: Avid Bioservices primarily serves biotech and pharmaceutical companies that require contract manufacturing services for their biopharmaceutical products. These customers range from startups with limited resources to large pharmaceutical companies seeking to outsource specific manufacturing processes.

    2. Value Proposition: Avid Bioservices offers its customers a comprehensive range of services, including process development, cGMP manufacturing, analytical testing, and regulatory support. By leveraging their expertise and state-of-the-art facilities, Avid Bioservices ensures high-quality and cost-effective manufacturing solutions, enabling their clients to focus on their core competencies.

    3. Channels: Avid Bioservices utilizes both direct and indirect channels to reach its target customers. Direct channels include a dedicated sales team that actively engages with potential clients through networking events, industry conferences, and online marketing efforts. Indirect channels involve collaborations with industry associations and partnerships with other service providers to expand their reach.

    4. Customer Relationships: Avid Bioservices aims to establish long-term relationships with its customers by providing personalized support and maintaining open lines of communication throughout the manufacturing process. They prioritize customer satisfaction and work closely with their clients to address any concerns or changes that may arise.

    5. Key Activities: Avid Bioservices' key activities revolve around process development, manufacturing, and testing of biopharmaceutical products. Their experienced team of scientists and engineers work diligently to optimize manufacturing processes, ensuring efficient and reliable production.

    6. Key Resources: The company's key resources include its state-of-the-art manufacturing facilities, advanced analytical equipment, and a highly skilled workforce. These resources enable Avid Bioservices to deliver high-quality products and meet the regulatory requirements of the industry.

    7. Key Partnerships: Avid Bioservices actively seeks strategic partnerships with other industry leaders to enhance its capabilities and expand its service offerings. By collaborating with complementary organizations, they can provide a broader range of solutions and stay at the forefront of technological advancements in the biopharmaceutical industry.

    8. Revenue Streams: Avid Bioservices generates revenue through contracts with its customers for manufacturing services. The revenue is primarily derived from the manufacturing fees charged based on the complexity and volume of the products being manufactured.

    9. Cost Structure: The company incurs costs related to facility maintenance, raw material procurement, labor, quality control, and regulatory compliance. Avid Bioservices aims to optimize its cost structure by ensuring operational efficiency and maintaining high-quality standards.


    Avid Bioservices Inc's business model canvas provides a comprehensive overview of the key elements that drive their success as a contract development and manufacturing organization in the biopharmaceutical industry. By understanding and analyzing these building blocks, Avid Bioservices can continuously refine its strategies, enhance its value proposition, and effectively serve its customers' evolving needs.

    Which companies are the competitors of Avid Bioservices Inc?


    Avid Bioservices Inc. operates in the highly competitive biotechnology industry, where numerous companies are vying for market share and prominence. In this section, we will explore some of the main competitors of Avid Bioservices Inc. and discuss their offerings, strengths, and weaknesses.

    Competitor 1: Catalent Inc.

    Catalent Inc. is a global leader in providing advanced delivery technologies, development solutions, and manufacturing services to the biopharmaceutical industry. With a wide range of capabilities, including drug development, clinical supply services, and commercial manufacturing, Catalent offers comprehensive solutions to its clients.


    • Extensive experience and expertise in drug development and manufacturing.
    • Strong global presence, with facilities in over 40 locations worldwide.
    • Diverse portfolio of services, allowing for a one-stop-shop approach for clients.
    • Proven track record of successful partnerships with major pharmaceutical companies.


    • Intense competition in the market may result in pricing pressures.
    • Dependence on a few key clients for a significant portion of revenue.
    • Potential challenges in integrating acquired companies and technologies.

    Competitor 2: Lonza Group Ltd.

    Lonza Group Ltd. is a Swiss multinational company that offers products and services in the fields of pharmaceuticals, biotechnology, and specialty ingredients. Lonza's Bioscience division provides a broad range of solutions, including cell and gene therapy development, viral vector manufacturing, and endotoxin detection assays.


    • Extensive expertise in cell and gene therapy, which is a rapidly growing segment of the biotech industry.
    • Strong focus on innovation and technology, enabling Lonza to stay ahead of emerging trends.
    • Global reach with manufacturing sites and offices in multiple countries.
    • Strong financial position, allowing for investments in research and development.


    • Increasing regulatory scrutiny in the biotech industry, which may affect the speed of product development and commercialization.
    • Competitive landscape with several companies offering similar services.
    • Potential challenges in scaling up manufacturing processes to meet growing demand.

    Competitor 3: Thermo Fisher Scientific Inc.

    Thermo Fisher Scientific Inc. is a leading provider of scientific research services, including instruments, consumables, software, and services. The company's Biosciences division offers a wide range of products and services, including bioproduction, cell culture, and gene editing solutions.


    • Extensive product portfolio covering various aspects of biotechnology research and manufacturing.
    • Strong brand recognition and reputation for high-quality products.
    • Global presence with a wide distribution network.
    • Continuous focus on innovation and new product development.


    • Competitive market with several established players.
    • Pricing pressures due to intense competition.
    • Potential challenges in effectively integrating and leveraging acquired companies and technologies.


    Avid Bioservices Inc. faces fierce competition in the biotechnology industry from companies like Catalent Inc., Lonza Group Ltd., and Thermo Fisher Scientific Inc. These competitors possess their unique strengths and weaknesses, and their ability to adapt to emerging trends and deliver high-quality services will determine their success in this rapidly evolving industry. Avid Bioservices Inc. needs to stay innovative, build strong partnerships, and differentiate itself to maintain a competitive edge in this challenging market.

    Avid Bioservices Inc SWOT Analysis


    Avid Bioservices Inc possesses several strengths that contribute to its success in the biopharmaceutical industry.

    1. Experience and Expertise: Avid Bioservices Inc has been in the industry for over 35 years, providing contract development and manufacturing services to a wide range of clients. This extensive experience has allowed the company to develop a deep understanding of the industry's best practices and standards.

    2. Strong Reputation: The company has built a strong reputation for delivering high-quality services and products to its clients. This reputation has been earned through its consistent track record of success and its commitment to meeting and exceeding client expectations.

    3. State-of-the-Art Facilities: Avid Bioservices Inc operates state-of-the-art facilities that are designed to meet the rigorous demands of biopharmaceutical production. These facilities are equipped with the latest technologies and equipment, allowing the company to deliver efficient and cost-effective manufacturing solutions.

    4. Diverse Client Base: Avid Bioservices Inc serves a diverse client base that includes both large pharmaceutical companies and emerging biotech firms. This diversity allows the company to mitigate risks associated with overreliance on a single client and provides a steady stream of revenue.


    Despite its strengths, Avid Bioservices Inc also faces certain weaknesses that could potentially impact its performance.

    1. Dependence on Client Contracts: Avid Bioservices Inc relies heavily on client contracts for its revenue generation. This dependence on contracts exposes the company to the risk of losing clients or experiencing delays in signing new contracts, which could result in a decline in revenue.

    2. Limited Product Portfolio: The company's product portfolio is relatively limited, primarily focusing on contract manufacturing and development services. This limited product offering may restrict its ability to capture a larger market share and diversify its revenue streams.

    3. Competitive Industry: The biopharmaceutical industry is highly competitive, with numerous well-established players and emerging companies. Avid Bioservices Inc faces intense competition from both domestic and international contract manufacturing organizations, which could impact its market share and profitability.


    Avid Bioservices Inc has identified several opportunities that it can capitalize on to drive future growth and success.

    1. Increasing Demand for Biopharmaceuticals: The global demand for biopharmaceutical products is continuously growing, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in healthcare technologies. Avid Bioservices Inc can leverage this increasing demand to expand its client base and increase its market share.

    2. Outsourcing Trend: Many pharmaceutical companies are increasingly outsourcing their manufacturing activities to specialized contract manufacturing organizations like Avid Bioservices Inc. This outsourcing trend presents an opportunity for the company to attract new clients and expand its service offerings.

    3. Emerging Markets: The biopharmaceutical market in emerging economies, such as China and India, is experiencing rapid growth. Avid Bioservices Inc can explore opportunities in these markets by establishing strategic partnerships or expanding its operations to tap into the growing demand for biopharmaceutical products.


    Avid Bioservices Inc faces certain threats that could potentially hinder its growth and profitability.

    1. Regulatory Compliance: The biopharmaceutical industry is subject to strict regulatory requirements and quality standards. Failure to comply with these regulations could result in penalties, legal actions, and damage to the company's reputation.

    2. Intellectual Property Risks: Avid Bioservices Inc may face intellectual property risks, particularly when working with client-owned proprietary technologies. Unauthorized use or disclosure of these technologies could lead to legal disputes and damage the company's reputation.

    3. Economic Volatility: Fluctuations in the global economy can impact the biopharmaceutical industry. Economic downturns can lead to reduced healthcare spending and delayed or canceled projects, which could negatively affect Avid Bioservices Inc's revenue and profitability.

    In conclusion, Avid Bioservices Inc's SWOT analysis highlights its strengths, weaknesses, opportunities, and threats. Despite facing some challenges, the company's strong reputation, experience, and state-of-the-art facilities provide a solid foundation for future growth. By capitalizing on opportunities and effectively managing threats, Avid Bioservices Inc can position itself for continued success in the biopharmaceutical industry.

    Key Takeaways

    • Avid Bioservices Inc is a publicly traded company, meaning it is owned by its shareholders.
    • The mission statement of Avid Bioservices Inc is to provide a comprehensive range of customized services to support the development and manufacturing of biopharmaceutical products.
    • Avid Bioservices Inc makes money by offering contract development and manufacturing services to biotechnology and pharmaceutical companies, generating revenue through service fees and product sales.
    • Avid Bioservices Inc's business model canvas includes key elements such as customer segments, value propositions, channels, customer relationships, revenue streams, key activities, key resources, key partnerships, and cost structure.
    • Competitors of Avid Bioservices Inc include other contract development and manufacturing organizations (CDMOs) such as Lonza Group, Catalent, and Samsung Biologics.
    • A SWOT analysis of Avid Bioservices Inc reveals its strengths in expertise and capabilities, opportunities in the growing biopharmaceutical market, weaknesses in its dependence on a limited number of clients, and threats from potential competition and regulatory changes.


    In conclusion, Avid Bioservices Inc is a leading contract development and manufacturing organization (CDMO) in the biopharmaceutical industry. The company is owned by Peregrine Pharmaceuticals, a biopharmaceutical company focused on developing innovative therapies for cancer and other diseases.

    The mission statement of Avid Bioservices Inc is to provide a comprehensive range of services to support the development and manufacturing of biopharmaceutical products, ultimately helping their clients bring life-saving treatments to market.

    Avid Bioservices Inc generates revenue through its contract manufacturing services, where they assist biopharmaceutical companies in the production of their drug candidates. This includes process development, manufacturing, and regulatory compliance services.

    The company's business model canvas explains how they create value for their customers by offering specialized expertise, state-of-the-art facilities, and a strong focus on quality and compliance. This allows Avid Bioservices Inc to establish long-term partnerships with their clients, ensuring continued revenue generation.

    In terms of competition, Avid Bioservices Inc faces competition from other CDMOs in the biopharmaceutical industry, such as Lonza Group, Catalent, and Patheon. These companies also offer contract manufacturing services and have a similar focus on supporting the development and production of biopharmaceutical products.

    Lastly, conducting a SWOT analysis of Avid Bioservices Inc reveals the company's strengths in its industry expertise, strong client relationships, and state-of-the-art facilities. They also face challenges such as intense competition and the need to continually invest in research and development to stay at the forefront of the industry. Overall, Avid Bioservices Inc is well-positioned to capitalize on the growing demand for contract manufacturing services in the biopharmaceutical sector.


    What are the results of Avid Bioservices?

    As an AI language model, I don't have access to real-time information or the ability to browse the internet. However, I can provide some general information about Avid Bioservices.

    Avid Bioservices is a contract development and manufacturing organization (CDMO) that provides biologics development and manufacturing services to the biotechnology and pharmaceutical industries. They specialize in the production of monoclonal antibodies, recombinant proteins, viral vectors, and other biologics.

    The company's financial results can vary over time, depending on various factors such as their client base, contracts, market demand, and industry trends. To obtain the most up-to-date and accurate information regarding Avid Bioservices' financial performance, it is recommended to check their official website or refer to financial reports and news updates from reliable sources.

    Who are Avid Biosciences competitors?

    Some competitors of Avid Biosciences include:

    1. Lonza Group AG
    2. Catalent Inc.
    3. Charles River Laboratories International Inc.
    4. WuXi Biologics
    5. Samsung Biologics
    6. Boehringer Ingelheim BioXcellence
    7. Fujifilm Diosynth Biotechnologies
    8. Thermo Fisher Scientific Inc.
    9. Cytovance Biologics
    10. LakePharma Inc.

    Please note that this list is not exhaustive, and there may be other competitors in the market as well.

    Who is the CEO of Avid Bioservices?

    The CEO of Avid Bioservices is Nicholas S. Green.

    Where is avid bioservices located?

    Avid Bioservices is located in Tustin, California, United States.

    Want to create a presentation now?

    • instantly

      Instantly Create A Deck

      Let PitchGrade do this for me

    • smile

      Hassle Free

      We will create your text and designs for you. Sit back and relax while we do the work.

    Explore More Content